Share Phio Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update as It Advances PH-762 Toward Phase 2b Study Initiation

Newsfile Corp · PHIO · November 5, 2026

Phio Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update as It Advances PH-762 Toward Phase 2b Study Initiation

Stocks To Buy Now app

Get the app for more

Explore stock news, insights and company research.

Get the app →
Source: Newsfile Corp ↗